The role of papillomavirus and herpesvirus infections in the origins and genesis of genital endometriosis. A literature review

Abstract

Endometriosis is a chronic multifactorial disease that affects one in ten women of reproductive age. Genetic, endocrine and immunological factors play an important role in the pathogenesis of endometriosis. In recent years, an increasing number of studies have been devoted to the role of vaginal microbiota in the pathogenesis of endometriosis. However, the role of viral infections, such as papillomavirus and herpesvirus infections, in the development of the disease has not been sufficiently studied. The review highlights current ideas about the role of human papillomavirus and herpesvirus infections in the genesis of endometriosis. The data obtained have convinced us of the need to further search for new relationships between papillomavirus and herpesvirus infections, microbiota of reproductive organs and pathogenesis of such a complicated disease as endometriosis.

Keywords

genital endometriosis / papillomavirus infection / herpesvirus infection / vaginal microbiota

References

[1] Yarmolinskaya MI, Aylamazyan EK. Genital’nyi ehndometrioz. Razlichnye grani problemy. Saint Petersburg: Eco-Vector; 2017. (In Russ.)

[2] Ярмолинская М.И., Айламазян Э.К. Генитальный эндометриоз. Различные грани проблемы. Санкт Петербург: Эко-Вектор, 2017.

[3] Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–1079. DOI: 10.1210/er.2018-00242

[4] Bulun S.E., Yilmaz B.D., Sison C., et al. Endometriosis // Endocr. Rev. 2019. Vol. 40, No. 4. P. 1048–1079. DOI: 10.1210/er.2018-00242

[5] Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2). DOI: 10.1093/hropen/hoac009

[6] Becker C.M., Bokor A., Heikinheimo O., et al. ESHRE guideline: endometriosis // Hum. Reprod. Open. 2022. Vol. 2022. No. 2. DOI: 10.1093/hropen/hoac009

[7] Gheit T. Mucosal and cutaneous human papillomavirus infections and cancer biology. Front Oncol. 2019;9:355. DOI: 10.3389/fonc.2019.00355

[8] Gheit T. Mucosal and cutaneous human papillomavirus infections and cancer biology // Front. Oncol. 2019. Vol. 9. P. 355. DOI: 10.3389/fonc.2019.00355

[9] Robadi IA, Pharaon M, Ducatman BS. The importance of high-risk human papillomavirus types other than 16 and 18 in cervical neoplasia. Arch Pathol Lab Med. 2018;142(6):693–695. DOI: 10.5858/arpa.2017-0563-RA

[10] Robadi I.A., Pharaon M., Ducatman B.S. The Importance of high-risk human papillomavirus types other than 16 and 18 in cervical neoplasia // Arch. Pathol. Lab. Med. 2018. Vol. 142. No. 6. P. 693–695. DOI: 10.5858/arpa.2017-0563-RA

[11] Zarochentseva NV, Krasnopolsky V., Belaya YuM. Рrogress in vaccination of HPV-associated diseases and cervical cancer in the world and in Russia. Literature review. Colposcopy Issues and Genital Infections. 2022;(1):8–16. (In Russ.) DOI: 10.46393/27826392_2022_1_8

[12] Зароченцева Н.В., Краснопольский В.И., Белая Ю.М. Успехи вакцинопрофилактики ВПЧ-ассоциированных заболеваний и рака шейки матки в мире и в России. Обзор литературы // Вопросы практической кольпоскопии. Генитальные инфекции. 2022. № 1. С. 8–16. DOI: 10.46393/27826392_2022_1_8

[13] Jeršovienė V, Gudlevičienė Ž, Rimienė J, et al. Human papillomavirus and infertility. Medicina (Kaunas). 2019;55(7):377. DOI: 10.3390/medicina55070377

[14] Jeršovienė V., Gudlevičienė Ž., Rimienė J., et al. Human papillomavirus and infertility // Medicina. 2019. Vol. 55. No. 7. P. 377. DOI: 10.3390/medicina55070377

[15] Capra G, Schillaci R, Bosco L, et al. HPV infection in semen: results from a new molecular approach. Epidemiol Infect. 2019;147. DOI: 10.1017/S0950268819000621

[16] Capra G., Schillaci R., Bosco L., et al. HPV infection in semen: results from a new molecular approach // Epidemiol. Infect. 2019. Vol. 147. DOI: 10.1017/S0950268819000621

[17] Isaguliants M, Krasnyak S, Smirnova O, et al. Genetic instability and anti-HPV immune response as drivers of infertility associated with HPV infection. Infect Agent Cancer. 2021;16(1):29. DOI: 10.1186/s13027-021-00368-1

[18] Isaguliants M., Krasnyak S., Smirnova O., et al. Genetic instability and anti-HPV immune response as drivers of infertility associated with HPV infection // Infect. Agent. Cancer. 2021. Vol. 16. No. 1. P. 29. DOI: 10.1186/s13027-021-00368-1

[19] Zacharis K, Messini CI, Anifandis G, et al. Human Papilloma Virus (HPV) and fertilization: a mini review. Medicina (Kaunas). 2018;54(4):50. DOI: 10.3390/medicina54040050

[20] Zacharis K., Messini C. I., Anifandis G., et al. Human papilloma virus (HPV) and fertilization: a mini review // Medicina (Kaunas). 2018. Vol. 54. No. 4. P. 50. DOI: 10.3390/medicina54040050

[21] Henneberg AA, Patton WC, Jacobson JD, et al. Human papilloma virus DNA exposure and embryo survival is stage-specific. J Assist Reprod Genet. 2006;23(6):255–259. DOI: 10.1007/s10815-006-9030-8

[22] Henneberg A.A., Patton W.C., Jacobson J.D., et al. Human papilloma virus DNA exposure and embryo survival is stage-specific // J. Assist. Reprod. Genet. 2006. Vol. 23. No. 6. P. 255–259. DOI: 10.1007/s10815-006-9030-8

[23] Hong LJ, Oshiro BT, Chan PJ. HPV-16 exposed mouse embryos: a potential model for pregnancy wastage. Arch Gynecol Obstet. 2013;287(6):1093–1097. DOI: 10.1007/s00404-013-2711-5

[24] Hong L.J., Oshiro B.T., Chan P.J. HPV-16 exposed mouse embryos: a potential model for pregnancy wastage // Arch. Gynecol. Obstet. 2013. Vol. 287. No. 6. P. 1093–1097. DOI: 10.1007/s00404-013-2711-5

[25] Gomez LM, Ma Y, Ho C, et al. Placental infection with human papillomavirus is associated with spontaneous preterm delivery. Hum Reprod. 2008;23(3):709–715. DOI: 10.1093/humrep/dem404

[26] Gomez L.M., Ma Y., Ho C., et al. Placental infection with human papillomavirus is associated with spontaneous preterm delivery // Hum. Reprod. 2008. Vol. 23. No. 3. P. 709–715. DOI: 10.1093/humrep/dem404

[27] Hermonat PL, Han L, Wendel PJ, et al. Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens. Virus Genes. 1997;14(1):13–17. DOI: 10.1023/a:1007975005433

[28] Hermonat P.L., Han L., Wendel P.J., et al. Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens // Virus Genes. 1997. Vol. 14. No. 1. P. 13–17. DOI: 10.1023/a:1007975005433

[29] Niyibizi J, Zanré N, Mayrand MH, et al. Association between maternal human papillomavirus infection and adverse pregnancy outcomes: systematic review and meta-analysis. J Infect Dis. 2020;221(12):1925–1937. DOI: 10.1093/infdis/jiaa054

[30] Niyibizi J., Zanré N., Mayrand M.H., et al. Association between maternal human papillomavirus infection and adverse pregnancy outcomes: systematic review and meta-analysis // J. Infect. Dis. 2020. Vol. 221. No. 12. P. 1925–1937. DOI: 10.1093/infdis/jiaa054

[31] Dassi L, Annunziata C, Botti C, et al. Detection of human papillomaviruses in the nasopharynx of breastfed infants: new findings and meta-analysis. Viruses. 2020;12(10):1119. DOI: 10.3390/v12101119

[32] Dassi L., Annunziata C., Botti C., et al. Detection of human papillomaviruses in the nasopharynx of breastfed infants: new findings and meta-analysis // Viruses. 2020. Vol. 12. No. 10. P. 1119. DOI: 10.3390/v12101119

[33] Prilepskaya VN, Dovlethanova ER. Papillomavirusnaya infektsiya: teoreticheskie I prakticheskie aspekty. Moscow: GEOTAR-Media; 2018. (In Russ.)

[34] Довлетханова Э.Р., Прилепская В.Н. Папилломавирусная инфек ция: теоретические и практические аспекты. Москва: ГЭОТАР-Медиа, 2018.

[35] Kiselev VI, Ashrafyan LA, Budarina CO, et al. Ehtiologicheskaya rol’ virusa papillomy cheloveka v razvitii raka sheiki matki: gene ticheskie i patogeneticheskie mekhanizmy, vozmozhnosti terapii i profilaktiki. Gynecology. 2004;6(4):174–180. (In Russ.)

[36] Киселев В.И., Ашрафян Л.А., Бударина С.О., и др. Этиологическая роль вируса папилломы человека в развитии рака шейки матки: генетические и патогенетические механизмы, возможности терапии и профилактики // Гинекология. 2004. Т. 6. № 4. C. 174–180.

[37] Shipulina OYu, Abramova MS, Korolenkova LI. Сomparative analysis of modern reagent kits on the basis of real time PCR for detection of HPV with a high carcinogenic risk in the framework of cervical screening. Issues of Practical. Colposcopy and Genital Infections. 2022;(3):26–32. (In Russ.) DOI: 10.46393/27826392_2022_3_26

[38] Шипулина О.Ю., Абрамова М.С., Короленкова Л.И. Сравнительный анализ эффективности российских ВПЧ-тестов на осно ве ПЦР в реальном времени для выявления ВПЧ высокого канцерогенного риска в программах цервикального скрининга // Вопросы практической кольпоскопии. Генитальные инфекции. 2022. № 3. С. 26–32. DOI: 10.46393/27826392_2022_3_26

[39] Rogovskaya SI, Trofimov DY, Kogan EA, et al. Clinical value of molecular markers in papillomavirus infection. Obstetrics and Gynecology. 2011;(4):4–10. (In Russ.)

[40] Роговская С.И., Трофимов Д.Ю., Коган Е.А., и др. Клиническое значение молекулярных маркеров при инфекции // Акушерство и гинекология. 2011. № 4. С. 4–10.

[41] Hibma MH. The immune response to papillomavirus during infection persistence and regression. Open Virol J. 2012;6:241–248. DOI: 10.2174/1874357901206010241

[42] Hibma M.H. The immune response to papillomavirus during infection persistence and regression // Open Virol. J. 2012. Vol. 6. P. 241–248. DOI: 10.2174/1874357901206010241

[43] Skinner SR, Wheeler CM, Romanowski B, et al. Progression of HPV infection to detectable cervical lesions or clearance in adult women: analysis of the control arm of the VIVIANE study. Int J Cancer. 2016;138(10):2428–2438. DOI: 10.1002/ijc.29971

[44] Skinner S.R., Wheeler C.M., Romanowski B., et al. Progression of HPV infection to detectable cervical lesions or clearance in adult women: analysis of the control arm of the VIVIANE study // Int. J. Cancer. 2016. Vol. 138. No. 10. P. 2428–2438. DOI: 10.1002/ijc.29971

[45] Prilepskaya VN, Gusakov KI, Nazarova NM. Vaccination as an effective method of prevention for cervical diseases associated with human papillomavirus (literature review). Gynecology. 2019;21(2):23–27. (In Russ.) DOI: 10.26442/20795696.2019.2.190396

[46] Прилепская В.Н., Гусаков К.И., Назарова Н.М. Вакцинация как эффективный метод профилактики заболеваний шейки матки, ассоциированных с вирусом папилломы человека (обзор литературы) // Гинекология. 2019. Т. 21. № 2. С. 23–27. DOI: 10.26442/20795696.2019.2.190396

[47] Lavagna A, Auger JP, Girardin SE, et al. Recognition of lipoproteins by Toll-like receptor 2 and DNA by the AIM2 inflammasome is responsible for production of interleukin-1β by virulent suilysin-negative streptococcus suis serotype 2. Pathogens. 2020;9(2):147. DOI: 10.3390/pathogens9020147

[48] Lavagna A., Auger J.P., Girardin S.E., et al. Recognition of lipoproteins by toll-like receptor 2 and DNA by the AIM2 inflammasome is responsible for production of interleukin-1β by virulent suilysin-negative streptococcus suis serotype 2 // Pathogens. 2020. Vol. 9. No. 2. P. 147. DOI: 10.3390/pathogens9020147

[49] Lebedeva OP, Kalutsky PV, Pakhomov SP, et al. Toll-like raceptors of female reproductive tract and their ligands. Challenges in modern medicine. 2010;12(22,93):31–35. (In Russ.)

[50] Лебедева О.П., Калуцкий П.В., Пахомов С.П., и др. Толл-подобные рецепторы женского репродуктивного тракта и их лиганды // Акту альные проблемы медицины. 2010. Т. 12. № 22 (93). С. 31–35.

[51] Amador-Molina A, Hernández-Valencia JF, Lamoyi E, et al. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. Viruses. 2013;5(11):2624–2642. DOI: 10.3390/v5112624

[52] Amador-Molina A., Hernández-Valencia J. F., Lamoyi E., et al. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response // Viruses. 2013. Vol. 5. No. 11. P. 2624–2642. DOI: 10.3390/v5112624

[53] Song D, Li H, Li H, et al. Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. Oncol Lett. 2015;10(2):600–606. DOI: 10.3892/ol.2015.3295

[54] Song D., Li H., Li H., et al. Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer // Oncol. Let. 2015. Vol. 10. No. 2. P. 600–606. DOI: 10.3892/ol.2015.3295

[55] Kedrova AG, Levakov SA, Tsarenko MD. Long-term results of treatment for benign cervical epithelial changes associated with human papillomavirus. Gynecology. 2016;12(2):77–83. (In Russ.) DOI: 10.17650/1994-4098-2016-12-2-77-83.

[56] Кедрова А.Г., Леваков С.А., Царенко М.Д. Отдаленные результаты лечения доброкачественных изменений эпителия шейки матки, ассоциированных с вирусом папилломы человека // Гинекология. 2016. Т. 12. № 2. С. 77–83. DOI: 10.17650/1994-4098-2016-12-2-77-83

[57] Daud II, Scott ME, Ma Y, et al. Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer. 2011;128(4):879–886. DOI: 10.1002/ijc.25400

[58] Daud I.I., Scott M.E., Ma Y., et al. Association between toll-like receptor expression and human papillomavirus type 16 persistence // Int. J. Cancer. 2011. Vol. 128. No. 4. P. 879–886. DOI: 10.1002/ijc.25400

[59] Gumilevskaya OP, Kiseleva TS, Ritter MA, et al. The role of allelic polymorphism of receptor genes of innate immunity in the persistence of human papillomavirus. Journal Infectology. 2016;8(4):46–49. (In Russ.) DOI: 10.22625/2072-6732-2016-8-4-46-49

[60] Гумилевская О.П., Киселева Т.С., Риттер М.А., и др. Роль аллельного полиморфизма генов рецепторов врожденного иммунитета в персистенции вируса папилломы человека // Журнал инфектологии. 2016. Т. 8. № 4. С. 46–49. DOI: 10.22625/2072-6732-2016-8-4-46-49

[61] Proshin SN, Glushakov RI, Shabanov PD, et al. The value of the expression of TLR-receptors for the selection of pharmacological correction of pathology of the cervix and endometrium. Genes and Cells. 2011;6(1):91–97. (In Russ.)

[62] Прошин С.Н., Глушаков Р.И., Шабанов П.Д., и др. Значение экспрессии TLR-рецепторов для выбора фармакологической коррекции патологии шейки матки и эндометрия // Гены и клетки. 2011. Т. 6. № 1. С. 91–97.

[63] Wahid B, Ali A, Idrees M, Rafique S. Immunotherapeutic strategies for sexually transmitted viral infections: HIV, HSV and HPV. Cell Immunol. 2016;310:1–13. DOI: 10.1016/j.cellimm.2016.08.001

[64] Wahid B., Ali A., Idrees M., et al. Immunotherapeutic strategies for sexually transmitted viral infections: HIV, HSV and HPV // Cell. Immunol. 2016. Vol. 310. P. 1–13. DOI: 10.1016/j.cellimm.2016.08.001

[65] Rossiyskoe obshchestvo akusherov-ginekologov. Klinicheskie rekomendatsii po diagnostike i lecheniyu zabolevaniy, soprovozhda yushchikhsya patologicheskimi vydeleniyami iz polovykh putey. 2nd edition. Moscow; 2019. (In Russ.) [cited 2023 Aug 13]. Available from: https://minzdrav.midural.ru/uploads/19.pdf

[66] Российское общество акушеров-гинекологов. Клинические рекомендации по диагностике и лечению заболеваний, сопровождающихся патологическими выделениями из половых путей. 2-е изд. Москва, 2019. 56 с. [дата обращения 13.08.2023]. Доступ по ссылке: https://minzdrav.midural.ru/uploads/19.pdf

[67] Allaband C, McDonald D, Vázquez-Baeza Y, et al. Microbiome 101: studying, analyzing, and interpreting gut microbiome data for clinicians. Clin Gastroenterol Hepatol. 2019;17(2):218–230. DOI: 10.1016/j.cgh.2018.09.017

[68] Allaband C., McDonald D., Vázquez-Baeza Y., et al. Microbiome 101: studying, analyzing, and interpreting gut microbiome data for clinicians // Clin. Gastroenterol. Hepatol. 2019. Vol. 17. No. 2. P. 218–230. DOI: 10.1016/j.cgh.2018.09.017

[69] Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature. 2007;449(7164):804–810. DOI: 10.1038/nature06244

[70] Turnbaugh P.J., Ley R.E., Hamady M., et al. The human microbiome project // Nature. 2007. Vol. 449. No. 7164. P. 804–810. DOI: 10.1038/nature06244

[71] France MT, Ma B, Gajer P, et al. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome. 2020;8(1):166. DOI: 10.1186/s40168-020-00934-6

[72] France M.T., Ma B., Gajer P., et al. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition // Microbiome. 2020. Vol. 8. No. 1. P. 166. DOI: 10.1186/s40168-020-00934-6

[73] Mitra A, MacIntyre DA, Marchesi JR, et al. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome. 2016;4(1):58. DOI: 10.1186/s40168-016-0203-0

[74] Mitra A., MacIntyre D.A., Marchesi J.R., et al. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? // Microbiome. 2016. Vol. 4. No. 1. P. 58. DOI: 10.1186/s40168-016-0203-0

[75] De Seta F, Lonnee-Hoffmann R, Campisciano G, et al. The vaginal microbiome: III. The vaginal microbiome in various urogenital disorders. J Low Genit Tract Dis. 2022;26(1):85–92. DOI: 10.1097/LGT.0000000000000645

[76] De Seta F., Lonnee-Hoffmann R., Campisciano G., et al. The vaginal microbiome: III. The vaginal microbiome in various urogenital disorders // J. Low. Genit. Tract. Dis. 2022. Vol. 26. No. 1. P. 85–92. DOI: 10.1097/LGT.0000000000000645

[77] Watts DH, Fazzari M, Minkoff H, et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis. 2005;191(7):1129–1139. DOI: 10.1086/427777

[78] Watts D.H., Fazzari M., Minkoff H., et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women // J. Infect. Dis. 2005. Vol. 191. No. 7. P. 1129–1139. DOI: 10.1086/427777

[79] Norenhag J, Du J, Olovsson M, et al. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG. 2020;127(2):171–180. DOI: 10.1111/1471-0528.15854

[80] Norenhag J., Du J., Olovsson M., et al. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis // BJOG. 2020. Vol. 127. No. 2. P. 171–180. DOI: 10.1111/1471-0528.15854

[81] Di Paola M, Sani C, Clemente AM, et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection. Sci Rep. 2017;7(1). DOI: 10.1038/s41598-017-09842-6

[82] Di Paola M., Sani C., Clemente A.M., et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection // Sci. Rep. 2017. Vol. 7. No. 1. DOI: 10.1038/s41598-017-09842-6

[83] Machado A, Cerca N. Influence of biofilm formation by gardnerella vaginalis and other anaerobes on bacterial vaginosis. J Infect Dis. 2015;212(12):1856–1861. DOI: 10.1093/infdis/jiv338

[84] Machado A., Cerca N. Influence of biofilm formation by gardnerella vaginalis and other anaerobes on bacterial vaginosis // J. Infect. Dis. 2015. Vol. 212. No. 12. P. 1856–1861. DOI: 10.1093/infdis/jiv338.

[85] Iakov DV, Isakov VA. New aspects in pathogenesis of herpes simplex infection (Review). The Bulletin of Hematology. 2016;12(4):13–18. (In Russ.)

[86] Исаков Д.В., Исаков В.А. Новые аспекты патогенеза простого герпеса // Вестник гематологии. 2016. Т. 12. № 4. С. 13–18.

[87] Meditsinskaya mikrobiologiya, virusologiya i immunologiya. Ed. by V.V. Zverev, M.N. Boychenko. Moscow: GEOTAR-Media; 2010. (In Russ.)

[88] Медицинская микробиология, вирусология и иммунология / под ред. В.В. Зверева, М.Н. Бойченко. Мoсква: ГЭОТАР-Медиа, 2010.

[89] Anogenital’naya gerpeticheskaya virusnaya infektsiya. Klini cheskie rekomendatsii. 2021. (In Russ.) [cited 13 Aug 2023]. Available from: https://roag-portal.ru/recommendations_gynecology

[90] Аногенитальная герпетическая вирусная инфекция. Клинические рекомендации. 2021 [дата обращения 13.08.2023]. Доступ по ссылке: https://roag-portal.ru/recommendations_gynecology

[91] James C, Harfouche M, Welton NJ, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020;98(5):315–329. DOI: 10.2471/BLT.19.237149

[92] James C., Harfouche M., Welton N.J., et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016 // Bull. World Health Organ. 2020. Vol. 98. No. 5. P. 315–329. DOI: 10.2471/BLT.19.237149

[93] Speck SH, Ganem D. Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe. 2010;8(1):100–115. DOI: 10.1016/j.chom.2010.06.014

[94] Speck S.H., Ganem D. Viral latency and its regulation: lessons from the gamma-herpesviruses // Cell Host. Microbe. 2010. Vol. 8. No. 1. P. 100–115. DOI: 10.1016/j.chom.2010.06.014

[95] Zhu S, Viejo-Borbolla A. Pathogenesis and virulence of herpes simplex virus. Virulence. 2021;12(1):2670–2702. DOI: 10.1080/21505594.2021.1982373

[96] Zhu S., Viejo-Borbolla A. Pathogenesis and virulence of herpes simplex virus // Virulence. 2021. Vol. 12. No. 1. P. 2670–2702. DOI: 10.1080/21505594.2021.1982373

[97] Shannon B, Gajer P, Yi TJ, et al. Distinct effects of the cervicovaginal microbiota and herpes simplex type 2 infection on female genital tract immunology. J Infect Dis. 2017;215(9):1366–1375. DOI: 10.1093/infdis/jix088

[98] Shannon B., Gajer P., Yi T.J., et al. Distinct effects of the cervicovaginal microbiota and herpes simplex type 2 infection on female genital tract immunology // J. Infect. Dis. 2017. Vol. 215. No. 9. P. 1366–1375. DOI: 10.1093/infdis/jix088

[99] Kaul R, Nagelkerke NJ, Kimani J, et al. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis. 2007;196(11):1692–1697. DOI: 10.1086/522006

[100] Kaul R., Nagelkerke N.J., Kimani J., et al. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections // J. Infect. Dis. 2007. Vol. 196. No. 11. P. 1692–1697. DOI: 10.1086/522006

[101] Cherpes TL, Meyn LA, Krohn MA, et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis. 2003;37(3):319–325. DOI: 10.1086/375819

[102] Cherpes T.L., Meyn L.A., Krohn M.A., et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis // Clin. Infect. Dis. 2003. Vol. 37. No. 3. P. 319–325. DOI: 10.1086/375819

[103] Cherpes TL, Melan MA, Kant JA, et al. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis. 2005;40(10):1422–1428. DOI: 10.1086/429622

[104] Cherpes T.L., Melan M.A., Kant J.A., et al. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization // Clin. Infect. Dis. 2005. Vol. 40. No. 10. P. 1422–1428. DOI: 10.1086/429622

[105] Tapilskaya NI, Vorobtsova IN, Glushakov RI. Spontaneous clearance of the human papilloma virus as a result of suppressive therapy with acyclic nucleosides of a recurrent herpes-viral infection. Gynecology. 2017;19(3):55–61. (In Russ.) DOI: 10.26442/2079-5696_19.3.55-61

[106] Тапильская Н.И., Воробцова И.Н., Глушаков Р.И. Спонтанный клиренс вируса папилломы человека в результате супрессивной терапии ациклическими нуклеозидами рецидивирующей герпес-вирусной инфекции, локализованной в области гениталий // Гинекология. 2017. Т. 19. № 3. С. 55–61. DOI: 10.26442/2079-5696_19.3.55-61

[107] Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379. DOI: 10.1136/bmj-2022-070750

[108] Horne A.W., Missmer S.A. Pathophysiology, diagnosis, and management of endometriosis // BMJ. 2022. Vol. 379. DOI: 10.1136/bmj-2022-070750

[109] Evans MB, Decherney AH. Fertility and endometriosis. Clin Obstet Gynecol. 2017;60(3):497–502. DOI: 10.1097/GRF.0000000000000295

[110] Evans M.B., Decherney A.H. Fertility and endometriosis // Clin. Obstet. Gynecol 2017. Vol. 60. No. 3. P. 497–502. DOI: 10.1097/GRF.0000000000000295

[111] Kolanska K, Alijotas-Reig J, Cohen J, et al. Endometriosis with infertility: a comprehensive review on the role of immune deregulation and immunomodulation therapy. Am J Reprod Immunol. 2021;85(3). DOI: 10.1111/aji.13384

[112] Kolanska K., Alijotas-Reig J., Cohen J., et al. Endometriosis with infertility: a comprehensive review on the role of immune deregulation and immunomodulation therapy // Am. J. Reprod. Immunol. 2021. Vol. 85. No. 3. DOI: 10.1111/aji.13384

[113] Jarmolinskaja MI. Genital’nyj jendometrioz: vlijanie gormonal’nyh, immunologicheskih i geneticheskih faktorov na razvitie, osobennosti techenija i vybor terapii. [dissertation]. SaintPetersburg; 2009. (In Russ.) [cited 2023 Sept 26]. Available from: https://www.dissercat.com/content/genitalnyi-endometrioz-vliyanie-gormonalnykh-immunologicheskikh-i-geneticheskikh-faktorov-na

[114] Ярмолинская М.И. Генитальный эндометриоз: влияние гормональных, иммунологических и генетических факторов на развитие, особенности течения и выбор терапии: дис. … д-ра мед. наук. Санкт Петербург, 2009 [дата обращения 26.09.2023]. Доступ по ссылке: https://www.dissercat.com/content/genitalnyi-endometrioz-vliyanie-gormonalnykh-immunologicheskikh-i-geneticheskikh-faktorov-na

[115] Králíčková M, Vetvicka V. Immunological aspects of endometriosis: a review. Ann Transl Med. 2015;3(11):153. DOI: 10.3978/j.issn.2305-5839.2015.06.08

[116] Králíčková M., Vetvicka V. Immunological aspects of endomet riosis: a review // Ann. Transl. Med. 2015. Vol. 3. No. 11. P. 153. DOI: 10.3978/j.issn.2305-5839.2015.06.08

[117] Osuga Y, Koga K, Hirota Y, et al. Lymphocytes in endometriosis. Am J Reprod Immunol. 2011;65(1):1–10. DOI: 10.1111/j.1600-0897.2010.00887.x

[118] Osuga Y., Koga K., Hirota Y., et al. Lymphocytes in endometriosis // Am. J. Reprod. Immunol. 2011. Vol. 65. No. 1. P. 1–10. DOI: 10.1111/j.1600-0897.2010.00887.x

[119] Riccio LDGC, Santulli P, Marcellin L, et al. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol. 2018;50:39–49. DOI: 10.1016/j.bpobgyn.2018.01.010

[120] Riccio L.D.G.C., Santulli P., Marcellin L., et al. Immunology of endometriosis // Best Pract. Res. Clin. Obstet. Gynaecol. 2018. Vol. 50. P. 39–49. DOI: 10.1016/j.bpobgyn.2018.01.010

[121] Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril. 2001;75(1):1–10. DOI: 10.1016/s0015-0282(00)01630-7

[122] Lebovic D.I., Mueller M.D., Taylor R.N. Immunobiology of endometriosis // Fertil. Steril. 2001. Vol. 75. No. 1. P. 1–10. DOI: 10.1016/s0015-0282(00)01630-7

[123] Symons LK, Miller JE, Kay VR, et al. The immunopathophysiology of endometriosis. Trends Mol Med. 2018;24(9):748–762. DOI: 10.1016/j.molmed.2018.07.004

[124] Symons L.K., Miller J.E., Kay V.R., et al. The immunopathophysiology of endometriosis // Trends Mol. Med. 2018. Vol. 24. No. 9. P. 748–762. DOI: 10.1016/j.molmed.2018.07.004

[125] Kobayashi H, Higashiura Y, Shigetomi H, et al. Pathogenesis of endometriosis: the role of initial infection and subsequent sterile inflammation (Review). Mol Med Rep. 2014;9(1):9–15. DOI: 10.3892/mmr.2013.1755

[126] Kobayashi H., Higashiura Y., Shigetomi H., et al. Pathogenesis of endometriosis: the role of initial infection and subsequent sterile inflammation (Review) // Mol. Med. Rep. 2014. Vol. 9. No. 1. P. 9–15. DOI: 10.3892/mmr.2013.1755

[127] Sobstyl M, Niedźwiedzka-Rystwej P, Grywalska E, et al. Toll-like receptor 2 expression as a new hallmark of advanced endometriosis. Cells. 2020;9(8). DOI: 10.3390/cells9081813

[128] Sobstyl M., Niedźwiedzka-Rystwej P., Grywalska E., et al. Toll-like receptor 2 expression as a new hallmark of advanced endometriosis // Cells. 2020. Vol. 9. No. 8. P. 1813. DOI: 10.3390/cells9081813

[129] Almasi MZ, Hosseini E, Jafari R, et al. Evaluation of Toll-like receptor 3 (TLR3) signaling pathway genes and its genetic polymorphisms in ectopic and eutopic endometrium of women with endometriosis. J Gynecol Obstet Hum Reprod. 2021;50(9). DOI: 10.1016/j.jogoh.2021.102153

[130] Almasi M.Z., Hosseini E., Jafari R., et al. Evaluation of Toll-like receptor 3 (TLR3) signaling pathway genes and its genetic polymorphisms in ectopic and eutopic endometrium of women with endometriosis // J. Gynecol. Obstet. Hum. Reprod. 2021. Vol. 50. No. 9. DOI: 10.1016/j.jogoh.2021.102153

[131] Hernandes C, Gueuvoghlanian-Silva BY, Monnaka VU, et al. Regulatory T cells isolated from endometriotic peritoneal fluid express a different number of Toll-like receptors. Einstein (Sao Paulo). 2020;18. DOI: 10.31744/einstein_journal/2020AO5294

[132] Hernandes C., Gueuvoghlanian-Silva B.Y., Monnaka V.U., et al. Regulatory T cells isolated from endometriotic peritoneal fluid express a different number of Toll-like receptors // Einstein. 2020. Vol. 18. DOI: 10.31744/einstein_journal/2020AO5294

[133] de Azevedo BC, Mansur F, Podgaec S. A systematic review of toll-like receptors in endometriosis. Arch Gynecol Obstet. 2021;304(2):309–316. DOI: 10.1007/s00404-021-06075-x

[134] de Azevedo B.C., Mansur F., Podgaec S. A systematic review of toll-like receptors in endometriosis // Arch. Gynecol. Obstet. 2021. Vol. 304. No. 2. P. 309–316. DOI: 10.1007/s00404-021-06075-x

[135] Salliss ME, Farland LV, Mahnert ND, et al. The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain. Hum Reprod Update. 2021;28(1):92–131. DOI: 10.1093/humupd/dmab035

[136] Salliss M.E., Farland L.V., Mahnert N.D., et al. The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain // Hum. Reprod. Update. 2021. Vol. 28. No. 1. P. 92–131. DOI: 10.1093/humupd/dmab035

[137] Chang CY, Chiang AJ, Lai MT, et al. A more diverse cervical microbiome associates with better clinical outcomes in patients with endometriosis: a pilot study. Biomedicines. 2022;10(1):174. DOI: 10.3390/biomedicines10010174

[138] Chang C.Y., Chiang A.J., Lai M.T., et al. A more diverse cervical microbiome associates with better clinical outcomes in patients with endometriosis: a pilot study // Biomedicines. 2022. Vol. 10. No. 1. P. 174. DOI: 10.3390/biomedicines10010174

[139] Hsu CY, Ke DS, Lin CL, et al. To investigate the risk of herpes zoster in women with endometriosis: a taiwan national population-based cohort study. Front Med (Lausanne). 2021;8. DOI: 10.3389/fmed.2021.584322

[140] Hsu C.Y., Ke D.S., Lin C.L., et al. To investigate the risk of herpes zoster in women with endometriosis: a taiwan national population-based cohort study // Front. Med. 2021. Vol. 8. DOI: 10.3389/fmed.2021.584322

[141] Oppelt P, Renner SP, Strick R, et al. Correlation of high-risk human papilloma viruses but not of herpes viruses or Chlamydia trachomatis with endometriosis lesions. Fertil Steril. 2010;93(6):1778–1786. DOI: 10.1016/j.fertnstert.2008.12.061

[142] Oppelt P., Renner S.P., Strick R., et al. Correlation of high-risk human papilloma viruses but not of herpes viruses or Chlamydia trachomatis with endometriosis lesions // Fertil. Steril. 2010. Vol. 93. No. 6. P. 1778–1786. DOI: 10.1016/j.fertnstert.2008.12.061

[143] Heidarpour M, Derakhshan M, Derakhshan-Horeh M, et al. Prevalence of high-risk human papillomavirus infection in women with ovarian endometriosis. J Obstet Gynaecol Res. 2017;43(1):135–139. DOI: 10.1111/jog.13188

[144] Heidarpour M., Derakhshan M., Derakhshan-Horeh M., et al. Prevalence of high-risk human papillomavirus infection in women with ovarian endometriosis // J. Obstet. Gynaecol. Res. 2017. Vol. 43. No. 1. P. 135–139. DOI: 10.1111/jog.13188

[145] Rocha RM, Souza RP, Gimenes F, et al. The high-risk human papillomavirus continuum along the female reproductive tract and its relationship to infertility and endometriosis. Reprod Biomed Online. 2019;38(6):926–937. DOI: 10.1016/j.rbmo.2018.11.032

[146] Rocha R.M., Souza R.P., Gimenes F., et al. The high-risk human papillomavirus continuum along the female reproductive tract and its relationship to infertility and endometriosis // Reprod. Biomed. Online. 2019. Vol. 38. No. 6. P. 926–937. DOI: 10.1016/j.rbmo.2018.11.032

RIGHTS & PERMISSIONS

Eсо-Vector